Lance R. Peterson

1.7k total citations
30 papers, 1.3k citations indexed

About

Lance R. Peterson is a scholar working on Infectious Diseases, Clinical Biochemistry and Pharmacology. According to data from OpenAlex, Lance R. Peterson has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 12 papers in Clinical Biochemistry and 10 papers in Pharmacology. Recurrent topics in Lance R. Peterson's work include Antimicrobial Resistance in Staphylococcus (17 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Lance R. Peterson is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (17 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Lance R. Peterson collaborates with scholars based in United States, Canada and Switzerland. Lance R. Peterson's co-authors include Gary A. Noskin, Valentina Stosor, Michael Postelnick, Dale N. Gerding, C E Fasching, Karen Willard‐Gallo, Joseph J. Goswitz, Claudine E. Fasching, Sharon L. Dooley and Connie Clabots and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Journal of Clinical Microbiology.

In The Last Decade

Lance R. Peterson

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lance R. Peterson United States	19	657	362	344	230	195	30	1.3k
Jeffrey J. Zuravleff United States	14	481 0.7×	241 0.7×	419 1.2×	294 1.3×	146 0.7×	20	1.5k
Paul B. Iannini United States	22	424 0.6×	514 1.4×	625 1.8×	288 1.3×	257 1.3×	43	1.6k
Alan I. Hartstein United States	18	595 0.9×	306 0.8×	447 1.3×	499 2.2×	105 0.5×	33	1.5k
Christopher W. Crank United States	19	842 1.3×	481 1.3×	462 1.3×	190 0.8×	218 1.1×	25	1.4k
Claudia K. Hoyen United States	18	656 1.0×	308 0.9×	295 0.9×	378 1.6×	132 0.7×	27	1.3k
T.G. Winstanley United Kingdom	13	252 0.4×	248 0.7×	392 1.1×	357 1.6×	262 1.3×	27	1.2k
R E Warren United Kingdom	19	349 0.5×	211 0.6×	287 0.8×	276 1.2×	225 1.2×	42	1.1k
C. G. Mayhall United States	20	967 1.5×	591 1.6×	418 1.2×	264 1.1×	397 2.0×	26	2.0k
Tanya Dvorak United States	20	524 0.8×	223 0.6×	312 0.9×	173 0.8×	123 0.6×	31	1.4k
Charles E. Stager United States	18	397 0.6×	243 0.7×	665 1.9×	174 0.8×	212 1.1×	36	1.3k

Countries citing papers authored by Lance R. Peterson

Since Specialization

Citations

This map shows the geographic impact of Lance R. Peterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lance R. Peterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lance R. Peterson more than expected).

Fields of papers citing papers by Lance R. Peterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lance R. Peterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lance R. Peterson. The network helps show where Lance R. Peterson may publish in the future.

Co-authorship network of co-authors of Lance R. Peterson

This figure shows the co-authorship network connecting the top 25 collaborators of Lance R. Peterson. A scholar is included among the top collaborators of Lance R. Peterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lance R. Peterson. Lance R. Peterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peterson, Lance R.. (2005). Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?. Clinical Infectious Diseases. 42(2). 224–233. 63 indexed citations

Price, Connie, Suzanne M. Paule, Gary A. Noskin, & Lance R. Peterson. (2003). Active Surveillance Reduces the Incidence of Vancomycin-Resistant Enterococcal Bacteremia. Clinical Infectious Diseases. 37(7). 921–928. 53 indexed citations

Gavin, Patrick J., et al.. (2003). Left-sided endocarditis caused by Pseudomonas aeruginosa: successful treatment with meropenem and tobramycin. Diagnostic Microbiology and Infectious Disease. 47(2). 427–430. 25 indexed citations

Mandell, Lionel A., Lance R. Peterson, Richard Wise, et al.. (2002). The Battle against Emerging Antibiotic Resistance: Should Fluoroquinolones Be Used to Treat Children?. Clinical Infectious Diseases. 35(6). 721–727. 58 indexed citations

Peterson, Lance R. & Gary A. Noskin. (2001). New Technology for Detecting Multidrug-Resistant Pathogens in the Clinical Microbiology Laboratory. Emerging infectious diseases. 7(2). 306–311. 31 indexed citations

Reiner, Sandra, et al.. (2000). Persistent contamination of fabric-covered furniture by vancomycin-resistant enterococci: Implications for upholstery selection in hospitals. American Journal of Infection Control. 28(4). 311–313. 59 indexed citations

Dooley, Sharon L., et al.. (2000). Evaluation of the centrifuged and Gram-stained smear, urinalysis, and reagent strip testing to detect asymptomatic bacteriuria in obstetric patients. American Journal of Obstetrics and Gynecology. 182(5). 1076–1079. 84 indexed citations

Millichap, J Gordon, et al.. (1996). Selection of Enterococcus faecium strains with stable and unstable resistance to the streptogramin RP 59500 using stepwise in vitro exposure. Diagnostic Microbiology and Infectious Disease. 25(1). 15–20. 12 indexed citations

Peterson, Lance R., et al.. (1996). Comparative in vitro activity of l-ofloxacin and FK037 to other agents against 10,040 fresh clinical isolates. International Journal of Antimicrobial Agents. 6(4). 201–221. 2 indexed citations

10.

Noskin, Gary A., et al.. (1995). Recovery of Vancomycin-Resistant Enterococci on Fingertips and Environmental Surfaces. Infection Control and Hospital Epidemiology. 16(10). 577–581. 232 indexed citations

11.

Moody, Julia, et al.. (1994). Bactericidal action of gentamicin against enterococci that are sensitive, or exhibit low- or high-level resistance to gentamicin. Diagnostic Microbiology and Infectious Disease. 19(1). 57–60. 2 indexed citations

12.

Goswitz, Joseph J., Karen Willard‐Gallo, C E Fasching, & Lance R. Peterson. (1992). Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing. Antimicrobial Agents and Chemotherapy. 36(5). 1166–1169. 95 indexed citations

13.

Barry, A L, L. Barth Reller, George H. Miller, et al.. (1992). Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides. Journal of Clinical Microbiology. 30(3). 585–589. 26 indexed citations

14.

Fasching, C E, Fred C. Tenover, Thomas G. Slama, et al.. (1991). gyrA Mutations in Ciprofloxacin-Resistant, Methicillin-Resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee. The Journal of Infectious Diseases. 164(5). 976–979. 31 indexed citations

15.

Fasching, Claudine E., et al.. (1991). Antibacterial activity of cefoperazone and cefoperazone plus sulbactam in a neutropenic site model. Diagnostic Microbiology and Infectious Disease. 14(2). 147–155. 1 indexed citations

16.

Peterson, Lance R.. (1990). Emergence of Ciprofloxacin Resistance in Nosocomial Methicillin-Resistant Staphylococcus aureus Isolates. JAMA Internal Medicine. 150(10). 2151–2151. 41 indexed citations

17.

Peterson, Lance R., et al.. (1989). Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. The American Journal of Medicine. 86(6). 801–808. 127 indexed citations

18.

Moody, Julia, Lance R. Peterson, & Dale N. Gerding. (1984). In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics. Antimicrobial Agents and Chemotherapy. 26(2). 256–259. 7 indexed citations

19.

Gerding, Dale N., et al.. (1980). Failure of single doses of cefazolin and cefamandole to penetrate experimental chronic Escherichia coli abdominal abscesses. Antimicrobial Agents and Chemotherapy. 17(6). 1023–1029. 9 indexed citations

20.

Peterson, Lance R., et al.. (1978). Therapy of Candida peritonitis: penetration of amphotericin B into peritoneal fluid. Postgraduate Medical Journal. 54(631). 340–342. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact